ResearcherCentre de Recherche sur l'InflammationActive in the last 2 years

Audrey Beaufils

ORCID-verified (high confidence)As of 15 November 2026

Matched on ORCID iD 0009-0002-2085-2860; OpenAlex author ID A5115540648.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1 (first author 1, last author 0)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 15

Papers, trials and grants by year

2026: 1 paper

Papers 1

Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer. First author DOI 10.1200/jco-26-00327 ↗

Closest collaborators

The 15 strongest of 15 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Emmanuel Mitry · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗
Thierry Conroy · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗
Rémy Nicolle · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗
Vinciane Rebours · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗
James Biagi · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗
Anthony Turpin · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗
Jerome F. Cros · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗
Nicolas Alejandro Fraunhoffer · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗
Louis de Mestier · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗
Aurélien Lambert · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗
Daniel John Renouf · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗
Pascal R. Hammel · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗
Jean-Baptiste Bachet · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗
Alice Chia-Chi Wei · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗
Nelson Dusetti · 1 shared paper, 2026
- Paper Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic C… DOI 10.1200/jco-26-00327 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.